Work

Acalabrutinib for Treatment of Steroid-Refractory Chronic Graft Versus Host Disease

Year: 2026

Type: article

Study design: Clinical Trial

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.jtct.2026.08.032

Authors: Joseph Pidala, Hannah Choe, Amin Alousi, Carrie L. Kitko, Lynn Onstad, Rohtesh Mehta, Gabriela Desatnik, Qian V. Wu, Stephanie J. Lee

Institutions: Moffitt Cancer Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The University of Texas MD Anderson Cancer Center, Vanderbilt University Medical Center, Fred Hutch Cancer Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca United States

OpenAlex ID: W7203833516

FWCI:

Cites: 33

Cited by:

Related to: 10